TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms

被引:91
作者
Akahane, T [1 ]
Akahane, M [1 ]
Shah, A [1 ]
Connor, CM [1 ]
Thorgeirsson, UP [1 ]
机构
[1] NCI, Cellular Carcinogenesis & Tumor Promot Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
TIMP-1; MMP; microvascular; endothelium; focal adhesion; VE-cadherin; PECAM-1; cytoskeleton; FAK; paxillin; PTEN;
D O I
10.1016/j.yexcr.2004.08.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It was reported over a decade ago that tissue inhibitor of metal loproteinases- I (TIMP-1) suppresses angiogenesis in experimental models but the mechanism is still incompletely understood. This in vitro study focused on the molecular basis of TIMP-1-mediated inhibition of endothelial cell (EC) migration, a key step in the angiogenic process. Both recombinant human TIMP-1 and the synthetic MMP inhibitors, GM6001 and MMP-2-MMP-9 Inhibitor 111, suppressed migration of human dermal microvascular endothelial cells (HDMVEC) in a close-dependent fashion. The MMP-dependent inhibition of migration was associated with increased expression of the junctional adhesion proteins, VE-cadherin and PECAM-1, and VE-cadherin accumulation at cell-cell junctions. TIMP-1 also caused MMP-independent dephosphorylation of focal adhesion kinase (FAK) (pY397) and paxillin, which was associated with reduced number of F-actin stress fibers and focal adhesions. Moreover, TIMP-1 stimulated expression of PTEN that has been shown to reduce phosphorylation of FAK and inhibit cell migration. Our data suggest that TIMP-I inhibits HDMVEC migration through MMP-dependent stimulation of VE-cadherin and MMP-independent stimulation of PTEN with subsequent dephosphorylation of FAK and cytoskeletal remodeling. Published by Elsevier Inc.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 51 条
  • [21] Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model
    Ikenaka, Y
    Yoshiji, H
    Kuriyama, S
    Yoshio, J
    Noguchi, R
    Tsujinoue, H
    Yanase, K
    Namisaki, T
    Imazu, H
    Masaki, T
    Fukui, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (03) : 340 - 346
  • [22] Ilic D, 1997, J CELL SCI, V110, P401
  • [23] Complex roles of tissue inhibitors of metalloproteinases in cancer
    Jiang, YF
    Goldberg, ID
    Shi, YE
    [J]. ONCOGENE, 2002, 21 (14) : 2245 - 2252
  • [24] INHIBITION OF ANGIOGENESIS BY TISSUE INHIBITOR OF METALLOPROTEINASE
    JOHNSON, MD
    KIM, HRC
    CHESLER, L
    TSAOWU, G
    BOUCK, N
    POLVERINI, PJ
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1994, 160 (01) : 194 - 202
  • [25] MT1-MMP, but not secreted MMPs, influences the migration of human microvascular endothelial cells in 3-dimensional collagen gels
    Koike, T
    Vernon, RB
    Hamner, MA
    Sadoun, E
    Reed, MJ
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 86 (04) : 748 - 758
  • [26] Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN
    Koul, D
    Parthasarathy, R
    Shen, RJ
    Davies, MA
    Jasser, SA
    Chintala, SK
    Rao, JS
    Sun, Y
    Benvenisite, EN
    Liu, TJ
    Yung, WKA
    [J]. ONCOGENE, 2001, 20 (46) : 6669 - 6678
  • [27] Lafleur MA, 2002, J CELL SCI, V115, P3427
  • [28] Interendothelial junctions: structure, signalling and functional roles
    Lampugnani, MG
    Dejana, E
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (05) : 674 - 682
  • [29] Tissue inhibitor of metalloprotease (TIMP)-1 and proliferative behaviour of clonal breast cancer cells
    Luparello, C
    Avanzato, G
    Carella, C
    Pucci-Minafra, I
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (03) : 235 - 244
  • [30] Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of β-catenin from membrane bound E-cadherin and formation of nuclear β-catenin/LEF-1 complex
    Mei, JM
    Borchert, GL
    Donald, SP
    Phang, JM
    [J]. CARCINOGENESIS, 2002, 23 (12) : 2119 - 2122